Pd L1 (updated 2024-12-17)

Farbenspiel RIP Emy Pepito kommt [upl. by El]

Farbenspiel RIP Emy Pepito kommt

Duration: 19:47
75 views | 1 month ago

GIVEAWAY MYTHIC ESSENTIAL SLEEVES [upl. by Hilaire]

GIVEAWAY MYTHIC ESSENTIAL SLEEVES

Duration: 0:51
135 views | 1 week ago

Reaching 44M in Hughs Damage Challenge with SS Hau NC Rosa and NC Blue Electricweak 3v3 [upl. by Kingston]

Reaching 44M in Hughs Damage Challenge with SS Hau NC Rosa and NC Blue Electricweak 3v3

Duration: 3:04
1.8K views | 3 months ago

PD L1 Scoring Song [upl. by Morganne453]

PD L1 Scoring Song

Duration: 1:57
137 views | 6 months ago

Lung Cancer PDL1 Johns Story medicalstories lungcancer lungcancerawarenessmonth [upl. by Wilow280]

Lung Cancer PDL1 Johns Story medicalstories lungcancer lungcancerawarenessmonth

Duration: 0:43
554 views | 1 month ago

이거암 면역항암제 원리 알고 치료 받아요 feat PDL1 [upl. by Ennazzus]

이거암 면역항암제 원리 알고 치료 받아요 feat PDL1

Duration: 0:48
12.2K views | 29 Jun 2022

Treatment of Stage IV NSCLC with High PDL1 and Atypical Mutation Lung Cancer OncTalk 2022 [upl. by Roxana719]

Treatment of Stage IV NSCLC with High PDL1 and Atypical Mutation Lung Cancer OncTalk 2022

Duration: 2:18
35 views | 28 Feb 2023

High PDL1Wait for Genetic Testing Results Before TreatmentTargeted Therapies in Lung Cancer 2023 [upl. by Dupuy]

High PDL1Wait for Genetic Testing Results Before TreatmentTargeted Therapies in Lung Cancer 2023

Duration: 2:09
72 views | 28 Aug 2023

Neoadjuvant atezolizumab for advanced cutaneous squamous cell carcinoma [upl. by Scribner]

Neoadjuvant atezolizumab for advanced cutaneous squamous cell carcinoma

Duration: 1:00
29 views | 2 weeks ago

Molecular Tumor Board Thoracic ARID1A and PDL1 present [upl. by Eisseb]

Molecular Tumor Board Thoracic ARID1A and PDL1 present

Duration: 4:56
190 views | 6 Oct 2022

Studies in AntiPDL1 Monotherapy for NSCLC Lung Cancer OncTalk 2022 [upl. by Adnic]

Studies in AntiPDL1 Monotherapy for NSCLC Lung Cancer OncTalk 2022

Duration: 8:03
36 views | 28 Feb 2023

Identifying biomarkers in cutaneous SCC for enhanced patient screening [upl. by Allecram225]

Identifying biomarkers in cutaneous SCC for enhanced patient screening

Duration: 0:35
3 views | 1 week ago

IOU YouTube How important is PDL2 in cancer immune evasion [upl. by Elrae]

IOU YouTube How important is PDL2 in cancer immune evasion

Duration: 0:56
365 views | 23 Feb 2022

Являются ли экспрессия PDL1 и мутационная нагрузка надежными предикторами иммунотерапии [upl. by Sybilla879]

Являются ли экспрессия PDL1 и мутационная нагрузка надежными предикторами иммунотерапии

Duration: 21:09
719 views | 7 months ago

Evaluating the CPS Denominator A Precision Pathology Training Video from Agilent [upl. by Daye]

Evaluating the CPS Denominator A Precision Pathology Training Video from Agilent

Duration: 7:29
139K views | 2 Sep 2020

The significance of PDL1 expression in NSCLC [upl. by Oigroeg831]

The significance of PDL1 expression in NSCLC

Duration: 3:22
161 views | 10 May 2021

是什么治愈了她的癌症？世界首例接受新型疗法的少女康复了！解密癌症系列第五期：CAR T疗法、PD 1 PD L1免疫治疗、靶向治疗，人类正在铸造战胜癌症的钥匙！ FDU 复旦人 [upl. by Amarillis]

是什么治愈了她的癌症？世界首例接受新型疗法的少女康复了！解密癌症系列第五期：CAR T疗法、PD 1 PD L1免疫治疗、靶向治疗，人类正在铸造战胜癌症的钥匙！ FDU 复旦人

Duration: 15:45
1 views | 1 month ago

16 FcγR3A polymorphism influences natural killer cell activation [upl. by Betthezel458]

16 FcγR3A polymorphism influences natural killer cell activation

Duration: 15:18
987 views | 4 Nov 2023

Computational design of autoinhibitory domains for a proteaseactivated PDL1 antagonist [upl. by Eynahpets]

Computational design of autoinhibitory domains for a proteaseactivated PDL1 antagonist

Duration: 1:11:19
70 views | 1 month ago

Biomarkers in RCC Treatment The Role of Sarcomatoid Features and Emerging Technologies [upl. by Duax]

Biomarkers in RCC Treatment The Role of Sarcomatoid Features and Emerging Technologies

Duration: 9:09
2.5K views | 10 Jul 2017

KRAS downregulates FAS death cell receptor expression on pancreatic cancer cells Code 724 [upl. by Jacquenetta]

KRAS downregulates FAS death cell receptor expression on pancreatic cancer cells Code 724

Duration: 7:06
107.6K views | 30 Jun 2022

Q1 PD1免疫療法如何個人化治療？ [upl. by Anelem]

Q1 PD1免疫療法如何個人化治療？

Duration: 0:51
101 views | 3 months ago

FAS interact with CD8a Tcells amp has inverse relation with KRAS Code 726 [upl. by Ger748]

FAS interact with CD8a Tcells amp has inverse relation with KRAS Code 726

Duration: 0:43
37 views | 2 months ago

The future role of neoadjuvant immunotherapies in advanced cSCC [upl. by Adnolay]

The future role of neoadjuvant immunotherapies in advanced cSCC

Duration: 5:44
13 views | 1 week ago

FAS interact with CD8a Tcells amp has inverse relation with KRAS Bioinformatics Results Code 727 [upl. by Bo727]

FAS interact with CD8a Tcells amp has inverse relation with KRAS Bioinformatics Results Code 727

Duration: 32:29
13 views | 1 month ago

Cancer chemotherapy Ar Lec 04 PD1PDL1 immune checkpoint inhibitors Dostarlimab [upl. by Layton663]

Cancer chemotherapy Ar Lec 04 PD1PDL1 immune checkpoint inhibitors Dostarlimab

Duration: 2:27
|

Melanoma e NSCLC refrattari agli anti PD1 e PDL1 una strategia innovativa [upl. by Ihcelek]

Melanoma e NSCLC refrattari agli anti PD1 e PDL1 una strategia innovativa

Duration: 3:48
|

AHEADMERIT firstline pembrolizumab and BNT113 in advanced HPV16 HNSCC [upl. by Koffler]

AHEADMERIT firstline pembrolizumab and BNT113 in advanced HPV16 HNSCC

Duration: 1:45
|

Impact of de novo autoimmune skin toxicities during therapy with ICIs [upl. by Carmita]

Impact of de novo autoimmune skin toxicities during therapy with ICIs

Duration: 0:45
|

Analysis of the 5year OS findings from the ATALANTE trial in ovarian cancer [upl. by Clemens86]

Analysis of the 5year OS findings from the ATALANTE trial in ovarian cancer

Duration:
|

Content Report
youtor.org / Youtor Videos converter © 2024